Mobile health platform for managing medications and drug labeling
Official title: Evaluating the Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe): a Cluster Randomized Trial
Run by Seoul National University · NCT06703697 · Data updated 2026-11-12
This study tests if a new mobile app for managing medications can help adults who take multiple drugs stick to their treatment plans better than using paper methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 79 Years |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Seoul National University Academic / other |
| Locations | 1 site (Seoul, Gwanak-gu) |
| Status | Recruiting |
| Started | August 12, 2024 |
| Main results expected | December 15, 2024 |
| Study ends | July 31, 2025 |
| Registry record updated | November 27, 2024 |
| Trial ID | NCT06703697 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 79 who speak Korean and are taking three or more medications.
✕Probably not a fit
Patients who are not taking multiple medications or who do not consent to participate may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cluster randomized trial aims to evaluate the effectiveness of eDrugSafe, a mobile web platform designed for electronic labeling and medication management, in improving medication adherence and self-efficacy among adults taking multiple medications. The study will compare the outcomes of participants using eDrugSafe with those receiving traditional paper methods of medication management. Additionally, it will assess the feasibility and acceptability of implementing eDrugSafe in community pharmacies. The primary focus is on enhancing the quality of life and reducing hospitalizations for participants.
Why it matters
Potential benefit: If successful, this platform could significantly improve medication adherence and self-management for patients on multiple medications.
How similar studies have gone: Other studies have shown promise in using mobile health platforms for medication management, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 to 79 years. 2. Individuals who can speak and understand Korean. 3. Possession of a personal electronic device capable of accessing mobile applications and web services over wireless internet (bring participants' own device, BYOD). 4. Patients taking three or more medications with at least one medication prescribed for 28 days or longer. 5. Individuals who have provided direct consent to participate in the study. Exclusion Criteria: 1. Individuals using any mobile web platform other than eDrugSafe for medication safety information purposes after enrollment. 2. Individuals who do not consent to participate in the study or who withdraw their consent.
Where it's running
-
Seoul National University
Seoul, Gwanak-gu, South Korea Recruiting
Study contacts
- Study coordinator: Jung-Mi Oh, Pharm.D
- Email: jmoh@snu.ac.kr
- Phone: +82 10 4880 5699
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tele-diabetes remote monitoring for kids with type 1 diabetes
This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.
-
Digital follow-up after thoracic surgery
This trial tests whether a digital follow-up program for adults discharged home after thoracic surgery can improve pain control and quality of life during the first 28 days after surgery compared with standard care.
-
WhatsApp-based person-centered self-care support for homebound older adults
This project will test whether six bi-weekly WhatsApp video calls with nurse case managers using a person-centered approach help homebound older adults improve self-care, independence, and well-being compared with conventional provider-led calls.
-
Text messaging program to engage first-time fathers during pregnancy
This study tests a text messaging program designed to help first-time dads stay involved during pregnancy and after the baby is born by sending them helpful information and resources.
-
Evaluation of a mobile app for cardiac patient follow-up
This study tests a mobile app to see if it helps people with atrial fibrillation and heart failure manage their health better at home.
-
Using the medidux smartphone app to manage discharge from the Acute Admission Unit
We will test whether adults discharged from the Acute Admission Unit with cough, back pain, or abdominal discomfort who use the medidux app are less likely to return or need extra medical visits within 7 days.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.